Global Pharmaceutical Glass Packaging Market

Pharmaceutical Glass Packaging Market Size, Share, Growth Analysis, By Material (Type I, Type II), By Product (Vials, Bottles), By Drug Type (Generic, Branded), By Region - Industry Forecast 2025-2032


Report ID: SQMIG15G2097 | Region: Global | Published Date: December, 2024
Pages: 207 | Tables: 91 | Figures: 71

Pharmaceutical Glass Packaging Market News

  • In October 2023, Gerresheimer AG announced the introduction of a premium quality range of glass vials that are intended for use in biologic medicines. This innovation seeks to improve the performance and safety of biologics by offering better sealing and sterility. The company plans to respond to the growing need for injectable biologic medicines.
  • In September 2023, SGD Pharma announced the expansion of its production capabilities with a new manufacturing facility in India. The new plant will focus on producing glass containers for injectables, reinforcing SGD Pharma’s commitment to supporting the growing pharmaceutical market in Asia while ensuring compliance with stringent international quality standards.
  • In August 2023, Owens-Illinois extended their offering by providing sustainable glass solutions for pharmaceutical products made with post-consumer recycled materials. This is in line with their policy aimed at reducing the carbon footprint in the present foam for packaging solutions, which focuses on ensuring the quality and safety of drugs without compromise, thus in response to the growing need for eco-friendly packaging solutions in the pharmaceutical sector.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Pharmaceutical Glass Packaging Market size was valued at USD 18 billion in 2022 and is poised to grow from USD 19.9 billion in 2023 to USD 41.7 billion by 2031, growing at a CAGR of 9.7% during the forecast period (2024-2031). 

The global pharmaceutical glass packaging market has access to its top players who compete aggressively by continually coming up with new ideas, output, and environmentally friendly practices to retain their competitive edge. The market is characterized by the presence of large corporations such as Corning Inc, Schott AG, SGD Pharma, Owens-Illinois, and Geeresheimer AG which manufacture and supply a wide range of glass packaging products including vials, bottles, and ampoules. These companies are investing in advanced manufacturing technologies and meeting stringent regulatory standards to address the rising demand for pharmaceutical packaging, especially for biologics and injectables. 'Gerresheimer AG (Germany) ', 'Corning Incorporated (USA) ', 'Nipro Corporation (Japan) ', 'SGD SA (SGD Pharma) (France) ', 'Stölzle-Oberglas GmbH (CAG Holding GmbH) (Austria) ', 'Bormioli Pharma S.p.A. (Italy) ', 'West Pharmaceutical Services Inc. (USA) ', 'Schott AG (Germany) ', 'Shandong Pharmaceutical Glass Co. Ltd. (China) ', 'Beatson Clark (United Kingdom) ', 'Arab Pharmaceutical Glass Co. (Egypt) ', 'Piramal Glass Private Limited (Piramal Group) (India) ', 'Sisecam Group (Turkey) ', 'Verallia (France) ', 'Shandong Yaowei Pharmaceutical Glass Co., Ltd. (China) ', 'Zhejiang Huachuang Pharmaceutical Glass Co., Ltd. (China) ', 'Changzhou Huaxing Pharmaceutical Glass Co., Ltd. (China) ', 'Jiangsu Huaxing Pharmaceutical Glass Co., Ltd. (China) ', 'Jiangsu Kaidi Pharmaceutical Glass Co., Ltd. (China) ', 'Jiangsu Yikang Pharmaceutical Glass Co., Ltd. (China)'

The rise in the use of biologics like monoclonal antibodies and vaccine will be a leading growth factor for the expansion of the global pharmaceutical glass packaging market. Biologics entail safe, sterile, and high-grade packaging to ensure their effectiveness, and this boosts the growth in demand for glass vials and syringes within the health sector.

Growing Demand for Biologic Drug Packaging: The increasing usage of biologics including, but not limited to, vaccines and monoclonal antibodies is driving the need for specialized glass packaging. Glass vials as well as syringes create a safe and sterile environment essential for the maintenance of stability and efficacy of these sensitive drugs which in turn causes packaging solutions to advance.

Asia-Pacific dominates the global pharmaceutical glass packaging market due to its rapidly expanding healthcare sector, large population base, and growing pharmaceutical production. The enhanced requirement for generic and biologic medicines in the region, coupled with the increased healthcare awareness calls for high-grade packaging solutions. In addition, the region is favored due to cheap production costs and supportive government policies for the pharmaceutical sector. As India and China are becoming major centers for the manufacture of pharmaceuticals, the need for the packaging of such medical products in glass vials, bottles, and ampoules is expected to increase, thereby reinforcing the Asia-Pacific regions dominance in the global pharmaceutical glass packaging market outlook.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Pharmaceutical Glass Packaging Market

Report ID: SQMIG15G2097

$5,300
BUY NOW GET FREE SAMPLE